EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
- Conditions
- Non Small Cell Lung Cancer
- Registration Number
- NCT00982605
- Lead Sponsor
- Heidelberg University
- Brief Summary
The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).
- Detailed Description
NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
- Age ≥ 18 years
- Samples are collected before surgery or before any therapy
- ECOG 0 or 1
- Clinical stage I-II, T1-2, N0-1, M0)
- Surgically respectable
- Patient with enlarged med. lymphnodes (control group)
- Previous RT/CHT
- Previous or current cancer of other entity
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care
🇩🇪Heidelberg, Germany
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care🇩🇪Heidelberg, GermanyMichael Kreuter, MDContact49 / 6221 / 396michael.kreuter@thoraxklinik-heidelberg.de